Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05968729 · ClinicalTrials.gov registry record · NA
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
A NA study of Anterior Cruciate Ligament Reconstruction, sponsored by University of Connecticut.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05968729: Recruiting NA study of Anterior Cruciate Ligament Reconstruction, sponsored by University of Connecticut.
NCT05968729 is a NA study of Anterior Cruciate Ligament Reconstruction that is actively recruiting participants, run by University of Connecticut. The registered enrollment target is 40 participants, below the 291-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05968729, a NA study of Anterior Cruciate Ligament Reconstruction, is actively recruiting participants, sponsored by University of Connecticut.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this work is to conduct a comparative research-focused study to evaluate the effectiveness of how purposefully induced asymmetric walking protocols restore healthy, symmetric limb loading in individuals following post-anterior cruciate ligament reconstruction (ACLR) surgery. Additionally, computational modeling and machine learning to model knee loading in the clinic to determine the optimal asymmetric walking protocol to restore healthy gait in post-ACLR individuals.
Primary Outcome
The rate at which the force is generated (Body Weight/sec). A decrease in loading rate would suggest that the participants adopted improved motor control while an increase would reflect impaired of motor control.
Conditions Studied
Interventions
- OTHER Active Comparator: 0.25 m/s asymmetric session first
- OTHER Active Comparator: 0.50 m/s asymmetric session first
Study Locations (1)
Connecticut
- University of Connecticut - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT05968729 shows while recruiting
NCT05968729 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 291-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Anterior Cruciate Ligament Reconstruction appearing as the primary indexed condition, and to 2 interventions - of which Active Comparator: 0.25 m/s asymmetric session first is the first listed.
NCT05968729 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05968729 about?
NCT05968729 is a clinical study titled "Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol". The purpose of this work is to conduct a comparative research-focused study to evaluate the effectiveness of how purposefully induced asymmetric walking protocols restore healthy, symmetric limb loading in individuals following post-anterior cruciate ligament reconstruction (ACLR) surgery. Additiona...
What is the current status of trial NCT05968729?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-09-01. Estimated completion is 2027-07-31.
What conditions does trial NCT05968729 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Reconstruction.
What interventions are being tested in trial NCT05968729?
The interventions under investigation include: Active Comparator: 0.25 m/s asymmetric session first (OTHER), Active Comparator: 0.50 m/s asymmetric session first (OTHER).
Who is sponsoring clinical trial NCT05968729?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05968729 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Reconstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05968729's enrollment target sits among peer trials
40 9th of 11 higher than 3 of 11 other Anterior Cruciate Ligament Reconstruction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Reconstruction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mental Imagery to Improve Quadriceps Strength Post Anterior Cruciate Ligament Reconstruction: a Feasibility Study
RECRUITING · NA
-
Immunometabolic Mechanisms of Blood Flow Restriction (BFR) Training After Anterior Cruciate Ligament Reconstruction
RECRUITING · NA
-
STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon
ACTIVE NOT RECRUITING · NA
-
The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
RECRUITING · Phase 2
-
Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees
RECRUITING · Phase 4
-
Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI